Skip to Main content Skip to Navigation
Journal articles

Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer

Julien Peron 1 Pascal Roy K. Ding W. R. Parulekar L. Roche M. Buyse
1 Biostatistiques santé
Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-02025627
Contributor : Laure-Hélène Davoine Connect in order to contact the contributor
Submitted on : Tuesday, February 19, 2019 - 5:20:57 PM
Last modification on : Wednesday, September 15, 2021 - 2:56:02 PM

Identifiers

  • HAL Id : hal-02025627, version 1

Collections

Citation

Julien Peron, Pascal Roy, K. Ding, W. R. Parulekar, L. Roche, et al.. Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer. Breast Cancer Research and Treatment, Springer Verlag, 2015, 112, pp.971-6. ⟨hal-02025627⟩

Share

Metrics

Record views

21